COVID-19 Impact on Global Sexually Transmitted Diseases (STD) Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 91 pages | ID: C5D93A3BFA4FEN
QYResearch

Abstracts

This report focuses on the global Sexually Transmitted Diseases (STD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sexually Transmitted Diseases (STD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Roche
• Gilead Sciences
• GlaxoSmithKline
• Johnson & Johnson
• Merck
• AbbVie
• Bayer
• Bristol-Myers Squibb
• Eli Lilly

Market segment by Type, the product can be split into

• Viral Infections
• Bacterial Infections
• Others

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Sexually Transmitted Diseases (STD) Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Sexually Transmitted Diseases (STD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Sexually Transmitted Diseases (STD) Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sexually Transmitted Diseases (STD) Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Viral Infections
  1.4.3 Bacterial Infections
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Sexually Transmitted Diseases (STD) Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Sexually Transmitted Diseases (STD) Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Sexually Transmitted Diseases (STD) Treatment Industry
    1.6.1.1 Sexually Transmitted Diseases (STD) Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Sexually Transmitted Diseases (STD) Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Sexually Transmitted Diseases (STD) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Sexually Transmitted Diseases (STD) Treatment Market Perspective (2015-2026)
2.2 Sexually Transmitted Diseases (STD) Treatment Growth Trends by Regions
  2.2.1 Sexually Transmitted Diseases (STD) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Sexually Transmitted Diseases (STD) Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Sexually Transmitted Diseases (STD) Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Sexually Transmitted Diseases (STD) Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Sexually Transmitted Diseases (STD) Treatment Players by Market Size
  3.1.1 Global Top Sexually Transmitted Diseases (STD) Treatment Players by Revenue (2015-2020)
  3.1.2 Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Sexually Transmitted Diseases (STD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sexually Transmitted Diseases (STD) Treatment Market Concentration Ratio
  3.2.1 Global Sexually Transmitted Diseases (STD) Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Treatment Revenue in 2019
3.3 Sexually Transmitted Diseases (STD) Treatment Key Players Head office and Area Served
3.4 Key Players Sexually Transmitted Diseases (STD) Treatment Product Solution and Service
3.5 Date of Enter into Sexually Transmitted Diseases (STD) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Sexually Transmitted Diseases (STD) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Type (2021-2026)

5 SEXUALLY TRANSMITTED DISEASES (STD) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020)
5.2 Global Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Sexually Transmitted Diseases (STD) Treatment Market Size (2015-2020)
6.2 Sexually Transmitted Diseases (STD) Treatment Key Players in North America (2019-2020)
6.3 North America Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020)
6.4 North America Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Sexually Transmitted Diseases (STD) Treatment Market Size (2015-2020)
7.2 Sexually Transmitted Diseases (STD) Treatment Key Players in Europe (2019-2020)
7.3 Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020)
7.4 Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Sexually Transmitted Diseases (STD) Treatment Market Size (2015-2020)
8.2 Sexually Transmitted Diseases (STD) Treatment Key Players in China (2019-2020)
8.3 China Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020)
8.4 China Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Sexually Transmitted Diseases (STD) Treatment Market Size (2015-2020)
9.2 Sexually Transmitted Diseases (STD) Treatment Key Players in Japan (2019-2020)
9.3 Japan Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020)
9.4 Japan Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size (2015-2020)
10.2 Sexually Transmitted Diseases (STD) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Sexually Transmitted Diseases (STD) Treatment Market Size (2015-2020)
11.2 Sexually Transmitted Diseases (STD) Treatment Key Players in India (2019-2020)
11.3 India Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020)
11.4 India Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size (2015-2020)
12.2 Sexually Transmitted Diseases (STD) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Sexually Transmitted Diseases (STD) Treatment Introduction
  13.1.4 Pfizer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Sexually Transmitted Diseases (STD) Treatment Introduction
  13.2.4 Roche Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Gilead Sciences
  13.3.1 Gilead Sciences Company Details
  13.3.2 Gilead Sciences Business Overview and Its Total Revenue
  13.3.3 Gilead Sciences Sexually Transmitted Diseases (STD) Treatment Introduction
  13.3.4 Gilead Sciences Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
  13.3.5 Gilead Sciences Recent Development
13.4 GlaxoSmithKline
  13.4.1 GlaxoSmithKline Company Details
  13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.4.3 GlaxoSmithKline Sexually Transmitted Diseases (STD) Treatment Introduction
  13.4.4 GlaxoSmithKline Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
  13.4.5 GlaxoSmithKline Recent Development
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Details
  13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.5.3 Johnson & Johnson Sexually Transmitted Diseases (STD) Treatment Introduction
  13.5.4 Johnson & Johnson Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
  13.5.5 Johnson & Johnson Recent Development
13.6 Merck
  13.6.1 Merck Company Details
  13.6.2 Merck Business Overview and Its Total Revenue
  13.6.3 Merck Sexually Transmitted Diseases (STD) Treatment Introduction
  13.6.4 Merck Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
  13.6.5 Merck Recent Development
13.7 AbbVie
  13.7.1 AbbVie Company Details
  13.7.2 AbbVie Business Overview and Its Total Revenue
  13.7.3 AbbVie Sexually Transmitted Diseases (STD) Treatment Introduction
  13.7.4 AbbVie Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
  13.7.5 AbbVie Recent Development
13.8 Bayer
  13.8.1 Bayer Company Details
  13.8.2 Bayer Business Overview and Its Total Revenue
  13.8.3 Bayer Sexually Transmitted Diseases (STD) Treatment Introduction
  13.8.4 Bayer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
  13.8.5 Bayer Recent Development
13.9 Bristol-Myers Squibb
  13.9.1 Bristol-Myers Squibb Company Details
  13.9.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.9.3 Bristol-Myers Squibb Sexually Transmitted Diseases (STD) Treatment Introduction
  13.9.4 Bristol-Myers Squibb Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
  13.9.5 Bristol-Myers Squibb Recent Development
13.10 Eli Lilly
  13.10.1 Eli Lilly Company Details
  13.10.2 Eli Lilly Business Overview and Its Total Revenue
  13.10.3 Eli Lilly Sexually Transmitted Diseases (STD) Treatment Introduction
  13.10.4 Eli Lilly Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
  13.10.5 Eli Lilly Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Sexually Transmitted Diseases (STD) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Sexually Transmitted Diseases (STD) Treatment Revenue
Table 3. Ranking of Global Top Sexually Transmitted Diseases (STD) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Viral Infections
Table 6. Key Players of Bacterial Infections
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Sexually Transmitted Diseases (STD) Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Sexually Transmitted Diseases (STD) Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Sexually Transmitted Diseases (STD) Treatment Players to Combat Covid-19 Impact
Table 13. Global Sexually Transmitted Diseases (STD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Sexually Transmitted Diseases (STD) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Sexually Transmitted Diseases (STD) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Regions (2015-2020)
Table 17. Global Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Sexually Transmitted Diseases (STD) Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Sexually Transmitted Diseases (STD) Treatment Players
Table 24. Global Sexually Transmitted Diseases (STD) Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Players (2015-2020)
Table 26. Global Top Sexually Transmitted Diseases (STD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Diseases (STD) Treatment as of 2019)
Table 27. Global Sexually Transmitted Diseases (STD) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Sexually Transmitted Diseases (STD) Treatment Product Solution and Service
Table 30. Date of Enter into Sexually Transmitted Diseases (STD) Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Sexually Transmitted Diseases (STD) Treatment Market Size Share by Type (2015-2020)
Table 34. Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Sexually Transmitted Diseases (STD) Treatment Market Size Share by Application (2015-2020)
Table 36. Global Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Sexually Transmitted Diseases (STD) Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2019-2020)
Table 40. North America Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2015-2020)
Table 42. North America Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2019-2020)
Table 46. Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2015-2020)
Table 48. Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2019-2020)
Table 52. China Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2015-2020)
Table 54. China Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2019-2020)
Table 58. Japan Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2015-2020)
Table 60. Japan Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2019-2020)
Table 64. Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2019-2020)
Table 70. India Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2015-2020)
Table 72. India Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2019-2020)
Table 76. Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Product
Table 88. Roche Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 89. Roche Recent Development
Table 90. Gilead Sciences Company Details
Table 91. Gilead Sciences Business Overview
Table 92. Gilead Sciences Product
Table 93. Gilead Sciences Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 94. Gilead Sciences Recent Development
Table 95. GlaxoSmithKline Company Details
Table 96. GlaxoSmithKline Business Overview
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 99. GlaxoSmithKline Recent Development
Table 100. Johnson & Johnson Company Details
Table 101. Johnson & Johnson Business Overview
Table 102. Johnson & Johnson Product
Table 103. Johnson & Johnson Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 104. Johnson & Johnson Recent Development
Table 105. Merck Company Details
Table 106. Merck Business Overview
Table 107. Merck Product
Table 108. Merck Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 109. Merck Recent Development
Table 110. AbbVie Company Details
Table 111. AbbVie Business Overview
Table 112. AbbVie Product
Table 113. AbbVie Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 114. AbbVie Recent Development
Table 115. Bayer Business Overview
Table 116. Bayer Product
Table 117. Bayer Company Details
Table 118. Bayer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 119. Bayer Recent Development
Table 120. Bristol-Myers Squibb Company Details
Table 121. Bristol-Myers Squibb Business Overview
Table 122. Bristol-Myers Squibb Product
Table 123. Bristol-Myers Squibb Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 124. Bristol-Myers Squibb Recent Development
Table 125. Eli Lilly Company Details
Table 126. Eli Lilly Business Overview
Table 127. Eli Lilly Product
Table 128. Eli Lilly Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020) (Million US$)
Table 129. Eli Lilly Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Viral Infections Features
Figure 3. Bacterial Infections Features
Figure 4. Others Features
Figure 5. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Sexually Transmitted Diseases (STD) Treatment Report Years Considered
Figure 10. Global Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Players in 2019
Figure 15. Global Top Sexually Transmitted Diseases (STD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Diseases (STD) Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Treatment Revenue in 2019
Figure 17. North America Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Pfizer Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 26. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Roche Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 28. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Gilead Sciences Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 30. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GlaxoSmithKline Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 32. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Johnson & Johnson Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 34. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Merck Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 36. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. AbbVie Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 38. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bayer Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 40. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Bristol-Myers Squibb Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 42. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Eli Lilly Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed